ABSTRACT:
Ten new cembranolides, (-)-(1R*,4R*,10R*)-4-methoxycembra-2E,7E,11Z-trien-20,10-olide (1), (-)-(1S*,4R*,10R*)-1-hydroxy-4-methoxycembra-2E,7E,11Z-trien-20,10-olide (2), Croton gratissimus Burch. (C. zambesicus Müll. Arg.; C. microbotryus Pax.) (Euphorbiaceae) grows on stony hillsides as a semi-deciduous tree species throughout much of the warmer and drier regions from South Africa, northeastwards to the horn of Africa. The leaves of this plant are ground with goat fat and those of two other Croton L. species, and the resulting paste is heated on coals and the fumes inhaled as a cure for insomnia. 1 A tea made from the leaves is taken for coughs in Botswana. 2 Watt and Breyer-Brandwijk 3 documented C. gratissimus as a remedy for fever, for treating bleeding gums and eye disorders, and as an ingredient used to "smoke" rheumatic patients. In South Africa, the leaves are dried and smoked for influenza, colds, and fevers. 4 The traditional use of this species for treating fevers, intermittent or otherwise, indicates its likely application as an antimalarial, since it is employed as such within the malaria endemic-region of southern Africa. In Nigeria, bark infusions of the species (as C.
zambesicus) are reported to treat malaria. 5 
RESULTS AND DISCUSSION
The combined hexane and methylene chloride extracts (showed to be similar by TLC analysis) and the ethyl acetate extract of the leaves of C. gratissimus were separated using repeated column chromatography over silica gel to yield ten new cembranolides, 1-10, all of which were colorless oils. These were obtained together with six known compounds, eudesm-
α-glutinol, 9 lupeol, 10 (+)-(1R*,4S*,10R*)-4-hydroxycembra-2E,7E,11Z-trien-20,10-olide (4a), and (+)-(1R*,10R*)-cembra-2E,4E,7E,11Z-tetraen-20,10-olide, which have been isolated previously from the bark of this species, 7 and 24-ethylcholesta-4,22-dien-3-one. 11 NMR analysis showed that purified cembranolides are unstable on standing, but appear to be stable in the unpurified form.
Compound 1 was identified as (-)-(1R*,4R*,10R*)-4-methoxycembra-2E,7E,11Z-trien-20,10-olide. The NMR spectra were very similar to those of (-)-(1R*,4R*,10R*)-4-hydroxycembra-2E,7E,11Z-trien-20,10-olide (1a), previously isolated from the bark, for which the relative configuration was deduced by comparison with that of the crystalline (+)-(1R*,2S*, 7S*,8S*,12R*)-7,8-epoxy-2,12-cyclocembra-3E,10Z-dien-20,10-olide isolated from the same source. 7 The HRMS indicated a molecular formula of Hz) common in the series isolated from the bark and leaves of the same species indicated that H-10 is β in all the compounds isolated. The specific rotation for compound 1 was found to be -11.5. Therefore, the structure of Thus, these protons were assigned as β. Specific rotation value of + 24.2 was measured for 7.
This compound was assigned as (+)-(5R*,10R*)-5-methoxycembra-1E,3E,7E,11Z, 15-pentaen-20,10-olide.
Compounds 8 and 9 were found to be C-7 epimers of each other and HRESIMS analysis indicated both had a molecular formula of C 20 H 30 O 3 . As with compound 4, they both had an isopropyl group at C-1, and hydroxy groups at C-1α and C-4α, but the ∆ 7 -double bond had differed considerably between compounds 8 and 9 (see Table 2 ). As with compound 4, the relative configuration of 8 and 9 could be determined using the NOESY spectrum. In both cases, correlations could be seen between the isopropyl group methyl and H 3 -18 proton resonances and so these groups were assigned as β. The acetate derivative of 8 was prepared in an attempt to produce a crystalline product for single crystal X-ray analysis, or a more stable compound for screening. Unfortunately, the derivative was not crystalline but was stable enough to undergo in vitro antiplasmodial screening against P. falciparum (CQS) D10 strain. Compounds 4a and 8a exhibited IC 50 values of 20.8 and 13.5 µg/mL, respectively, compared to chloroquine (IC 50 27.0 ng/mL).
EXPERIMENTAL SECTION
General Experimental Procedures. Specific rotations were measured at room temperature in chloroform using a JASCO P-1020 polarimeter and IR spectra were recorded using a PerkinElmer (2000 FTIR) spectrometer. Samples were dissolved in chloroform and analyzed using NaCl plates. NMR spectra were recorded on a Bruker AVANCE 500 NMR spectrometer in Tables 1 and 2 , respectively. Quantitative assessment of antiplasmodial activity in vitro was determined via the parasite lactate dehydrogenase assay using a modified method described by Makler. 19 The two extracts were dissolved and diluted to give a 2 mg/mL stock solution in 10% DMSO and sonicated to enhance solubility. Samples were tested as a suspension if not completely dissolved. Stock solutions were stored at -20 º C. Further dilutions were prepared on the day of the experiment in complete medium. Chloroquine was used as the reference drug in all experiments. A full dose-response was performed for all compounds to determine the concentration inhibiting 50% of parasite growth (IC 50 -value). Test samples were tested at a starting concentration of 100 µg/mL, which was serially diluted 2-fold in complete medium to give 10 concentrations, with the lowest concentration being 0.2 µg/mL. Chloroquine was tested at a starting concentration of 100 ng/mL.
Acetylation of (+)-(1S*,4S*,7R*,10R*)-1,4,7-Trihydroxycembra-2E,8(19)
,
(-)-(1S*,4S*,7S*,10R*)-1,4,7-trihydroxycembra-2E,8(19),11Z-trien-20,10-olide (9):
The highest concentration of solvent to which the parasites were exposed had no measurable effect on the parasite viability (data not shown). The IC 50 values were obtained using a nonlinear dose-response curve fitting analysis using Graph Pad Prism v. 4.0 software. 
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